The most important financial indicators for the company Cygnus Med S.r.l. - Unique Identification Number 21526190:
sales in 2023 was
104.254
euro, registering a net profit of
64.525
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate.
In the last year of activity, the sales increased by 3.5%, from 101.026 euro in the year 2022, to 104.254 euro in 2023.
The Net Profit increased by 11.126 euro, from 53.561 euro in 2022, to 64.525 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Cygnus Med S.r.l. - CUI 21526190
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
29.572
18.702
7.122
1.643
1.971
48.438
183.808
223.452
207.356
190.046
Current Assets
71.126
135.679
195.513
66.074
85.305
60.083
17.219
67.377
100.543
117.871
Inventories
2.049
2.067
2.068
2.033
2.240
2.196
0
0
142
142
Receivables
1.877
2.376
1.873
1.865
1.317
1.346
2.838
6.263
6.216
11.440
Cash
67.200
131.236
191.571
62.176
81.749
56.541
14.381
61.114
94.184
106.289
Shareholders Funds
98.914
150.613
196.667
56.461
84.143
100.730
185.712
249.791
304.127
307.080
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
2.028
3.962
5.967
11.256
3.133
7.791
15.424
41.497
4.143
1.136
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"7219 - 7219"
CAEN Financial Year
7320
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
117.871 euro in 2023 which includes Inventories of
142 euro, Receivables of
11.440 euro and cash availability of
106.289 euro.
The company's Equity was valued at
307.080 euro, while total Liabilities amounted to
1.136 euro.
Equity increased by 3.876 euro, from 304.127 euro in 2022, to 307.080 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Cygnus Med S.r.l.